Case number 1:19-cv-00634
Ferring Pharmaceuticals Inc. et al v. Hetero USA Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (10) |
| Jul 11, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for D.I. 10 has been replaced with an amended version (see D.I. [12], [13]). The NEF for the filing has been regenerated. (nms) |
| Jul 11, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [9]. (nms) |
| Jul 11, 2019 | 12 | Letter (1) |
| Jul 11, 2019 | 12 | Exhibit (4) |
| Jul 11, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The proposed redacted filing at D.I. [12] is APPROVED. Ordered by Judge Richard G. Andrews on 7/11/2019. (nms) |
| Jul 11, 2019 | 14 | Patent/Trademark Report to Commissioner (1) |
| Jul 11, 2019 | 14 | Voluntary Dismissal (4) |
| Jul 11, 2019 | 12 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel M. Attaway, regarding response to the Court's July 9, 2019 oral order (D.I. [11]). (Attachments: # (1) Exhibit)(Attaway, Daniel) Modified on 7/11/2019 (nms). |
| Jul 11, 2019 | 14 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083. (Attachments: # (1) Voluntary Dismissal)(nms) |
| Jul 9, 2019 | 10 | Redacted Document (4) Docket Text: REDACTED VERSION of [9] Stipulation of Dismissal by Ferring International Center S.A., Ferring Pharmaceuticals Inc.. (Bourke, Mary) (Main Document 10 replaced on 7/11/2019) (nms). |
| Jul 9, 2019 | N/A | Oral Order (0) |
| May 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Complaint to July 8, 2019. Signed by Judge Richard G. Andrews on 5/17/2019. (nms) |
| Apr 10, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Apr 8, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Ferring Pharmaceuticals Inc., Ferring International Center S.A.. Hetero USA Inc. served on 4/5/2019, answer due 4/26/2019. (Bourke, Mary) |
| Apr 8, 2019 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Ferring Pharmaceuticals Inc., Ferring International Center S.A.: For Hetero Labs Limited waiver sent on 4/8/2019, answer due 7/8/2019; Hetero Labs Limited Unit-V waiver sent on 4/8/2019, answer due 7/8/2019. (Bourke, Mary) |
| Apr 8, 2019 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Complaint to July 8, 2019 - filed by Ferring International Center S.A., Ferring Pharmaceuticals Inc.. (Bourke, Mary) |
| Apr 5, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hetero USA Inc. on 4/5/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Apr 4, 2019 | 1 | Exhibit A (8) |
| Apr 4, 2019 | 1 | Exhibit B (8) |
| Apr 4, 2019 | 1 | Civil Cover Sheet (1) |
| Apr 4, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Apr 4, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/19/2019. Date of Expiration of Patent: 10/10/2028.Thirty Month Stay Deadline: 8/19/2021. (ceg) |
| Apr 4, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083. (ceg) |
| Apr 4, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ferring Holding S.A. for Ferring International Center S.A.; Corporate Parent Ferring Holding Inc. for Ferring Pharmaceuticals Inc. filed by Ferring International Center S.A., Ferring Pharmaceuticals Inc. (ceg) |
| Apr 4, 2019 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2611273.) - filed by Ferring Pharmaceuticals Inc., Ferring International Center S.A. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(ceg) |
| Apr 4, 2019 | 1 | Complaint* (1) |
